Multiple Sclerosis
Search for publications
Only original articles, editorials, guidelines.
-
Sainz de la Maza S, Sabin Muñoz J, Pilo de la Fuente B, Thuissard I, Andreu-Vázquez C, Galán Sánchez-Seco V, Salgado-Cámara P, Costa-Frossard L, Monreal E, Ayuso-Peralta L, García-Vasco L, García-Domínguez JM, Martínez-Ginés ML, Muñoz Fernández C, Díaz-Díaz J, Oreja-Guevara C, Gómez-Moreno M, Martín H, Rubio-Flores L, Blasco MR, Villar-Guimerans LM, Aladro Y.
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS . 59: 103669-103669. Number of citations: 3
-
Sainz de la Maza S, Maurino J, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco MR, García-Soto JD, Campo-Amigo MD, Navarro-Cantó L, Agüera E, Garcés M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, de Alda LR, Gómez-Ballesteros R, Castillo-Triviño T.
Measuring productivity loss in early relapsing-remitting multiple sclerosis
MULTIPLE SCLEROSIS AND RELATED DISORDERS . 58: 103398-103398. Number of citations: 4
-
Mena J, Alloza I, Tulloch Navarro R, Aldekoa A, Díez García J, Villanueva Etxebarria A, Lindskog C, Antigüedad A, Boyero S, Mendibe-Bilbao MDM, Álvarez de Arcaya A, Sánchez Menoyo JL, Midaglia L, Villarrubia N, Malhotra S, Montalban X, Villar LM, Comabella M, Vandenbroeck K.
Genomic Multiple Sclerosis Risk Variants Modulate the Expression of the ANKRD55-IL6ST Gene Region in Immature Dendritic Cells
Frontiers in immunology . 12: 816930-816930. Number of citations: 6
-
Pestaña D, Villar L, Gomez-Rojo M, Roy G, Olmedillo B, Giménez C, Zambrana P, Guisado G, Aláez A, Bardi T.
Respiratory mechanics in late COVID-19 ARDS - a restrictive pattern is strongly associated with death. A cohort study.
Anaesthesiology Intensive Therapy . 54(4): 295-301.
-
Coll-Martinez C, Quintana E, Salavedra-Pont J, Buxó M, González-Del-Rio M, Gómez I, Muñoz-San Martín M, Villar LM, Álvarez-Bravo G, Robles-Cedeño R, Ramió-Torrentà L, Gich J.
Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
BRAIN AND BEHAVIOR . 11(12): .
-
Pérez-Pérez S, Domínguez-Mozo MI, García-Martínez MÁ, García-Frontini MC, Villarrubia N, Costa-Frossard L, Villar LM, Arroyo R, Álvarez-Lafuente R.
Anti-Human Herpesvirus 6 A/B Antibodies Titers Correlate With Multiple Sclerosis-Associated Retrovirus Envelope Expression.
Frontiers in immunology . 12: 798003-798003. Number of citations: 2
-
Comabella M, Sastre-Garriga J, Borras E, Villar LM, Saiz A, Martínez-Yélamos S, García-Merino JA, Pinteac R, Fissolo N, Sánchez López AJ, Costa-Frossard L, Blanco Y, Llufriu S, Vidal-Jordana A, Sabidó E, Montalban X.
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis.
Neurology(R) neuroimmunology & neuroinflammation . 8(6): . Number of citations: 9
-
Moreno-Torres I, Meca Lallana V, Costa-Frossard L, Oreja-Guevara C, Aguirre C, Alba Suárez EM, Gómez Moreno M, Borrega Canelo L, Muñoz JS, Aladro Y, Cárcamo Fonfría A, Rodríguez García E, Cuello JP, Monreal E, Sainz de la Maza S, Pérez Parra F, Valenzuela Rojas F, López de Silanes de Miguel C, Casanova I, Martínez M, Blasco R, Orviz García A, Villar-Guimerans LM, Fernández-Dono G, Elvira V, Santiuste C, Espiño M, García Domínguez JM.
Risk and outcomes of covid-19 in patients with multiple sclerosis.
EUROPEAN JOURNAL OF NEUROLOGY . 28(11): 3712-3721. Number of citations: 19
-
Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernández-Velasco JI, Lapuente P, Comabella M, Ramió-Torrentà L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodríguez-Martín E, Roldán E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM.
Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab
Frontiers in immunology . 12: 760546-760546. Number of citations: 1
-
Fernandez O, Costa-Frossard L.
Integrated Management of Multiple Sclerosis Spasticity and Associated Symptoms Using the Spasticity-Plus Syndrome Concept: Results of a Structured Specialists' Discussion Using the Workmat(®) Methodology.
Frontiers in Neurology . 12: 722801-722801. Number of citations: 5
-
Mestre L, Alonso G, Feliú A, Mecha M, Martín C, Villar LM, Guaza C.
Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis
Aging Cell . 20(9): . Number of citations: 1
-
Monreal E, Sainz de la Maza S, Costa-Frossard L, Walo-Delgado P, Zamora J, Fernández-Velasco JI, Villarrubia N, Espiño M, Lourido D, Lapuente P, Toboso I, Álvarez-Cermeño JC, Masjuan J, Villar LM.
Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome
Neurology(R) neuroimmunology & neuroinflammation . 8(5): . Number of citations: 12
-
Dema M, Eixarch H, Villar LM, Montalban X, Espejo C.
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets
AUTOIMMUNITY REVIEWS . 20(9): 102893-102893. Number of citations: 20
-
Meca-Lallana JE, Maurino J, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Gómez-Ballesteros R, Ballesteros J.
Quantifying the patient´s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
Plos One . 16(7): .
-
Picón C, Tejeda-Velarde A, Fernández-Velasco JI, Comabella M, Álvarez-Lafuente R, Quintana E, Sainz de la Maza S, Monreal E, Villarrubia N, Álvarez-Cermeño JC, Domínguez-Mozo MI, Ramió-Torrentà L, Rodríguez-Martín E, Roldán E, Aladro Y, Medina S, Espiño M, Masjuan J, Matute-Blanch C, Muñoz-San Martín M, Espejo C, Guaza C, Muriel A, Costa-Frossard L, Villar LM.
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
Frontiers in immunology . 12: 685139-685139. Number of citations: 5
-
Arrambide G, Llaneza-González MÁ, Costa-Frossard França L, Meca-Lallana V, Díaz EF, Moreno-Torres I, García-Domínguez JM, Ortega-Suero G, Ayuso-Peralta L, Gómez-Moreno M, Sotoca-Fernández JJ, Caminero-Rodríguez AB, Rodríguez de Antonio LA, Corujo-Suárez M, Otano-Martínez MA, Pérez-Miralles FC, Reyes-Garrido V, Ayuso-Blanco T, Balseiro-Gómez JJ, Muñoz-Pasadas M, Pérez-Molina I, Arnal-García C, Domingo-Santos Á, Guijarro-Castro C, Íñiguez-Martínez C, Téllez Lara N, Castellanos-Pinedo F, Castillo-Triviño T, Cerdán-Santacruz DM, Pérez-Sempere Á, Torres BS, Álvarez de Arcaya A, Costa-Arpín E, Durán-Ferreras E, Fragoso-Martínez M, González-Platas M, Landete Pascual L, Millán-Pascual J, Oreja-Guevara C, Meca-Lallana JE.
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.
Neurology(R) neuroimmunology & neuroinflammation . 8(5): . Number of citations: 16
-
Hernández-Breijo B, Plasencia-Rodríguez C, Navarro-Compán V, García-Hoz C, Nieto-Gañán I, Sobrino C, Bachiller-Corral J, Díaz-Almirón M, Martínez-Feito A, Jurado T, Lapuente-Suanzes P, Bonilla G, Pijoán-Moratalla C, Roy G, Vázquez-Díaz M, Balsa A, Villar LM, Pascual-Salcedo D, Rodríguez-Martín E.
Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis.
Frontiers In Medicine . 8: 683990-683990. Number of citations: 2
-
Fernández O, Montalban X, Aladro Y, Alonso A, Arroyo R, Calles C, Castillo-Triviño T, Comabella M, Costa-Frossard L, Forero L, Ginestal R, Landete L, Llaneza M, Llufriu S, Martínez-Ginés ML, Meca-Lallana J, Mendibe M, Oreja-Guevara C, Oterino A, Prieto JM, Ramió-Torrentà L, Romero-Pinel L, Téllez N, Rodríguez-Antigüedad A.
XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II).
REVISTA DE NEUROLOGIA . 72(12): 433-442.